GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeline Scientific Inc (LSE:LSI) » Definitions » EV-to-FCF

Lifeline Scientific (LSE:LSI) EV-to-FCF : 5.99 (As of Jun. 01, 2024)


View and export this data going back to . Start your Free Trial

What is Lifeline Scientific EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Lifeline Scientific's Enterprise Value is £26.67 Mil. Lifeline Scientific's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2016 was £4.45 Mil. Therefore, Lifeline Scientific's EV-to-FCF for today is 5.99.

The historical rank and industry rank for Lifeline Scientific's EV-to-FCF or its related term are showing as below:

LSE:LSI's EV-to-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 27.045
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-01), Lifeline Scientific's stock price is £1.37. Lifeline Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2016 was £0.000. Therefore, Lifeline Scientific's PE Ratio for today is N/A.


Lifeline Scientific EV-to-FCF Historical Data

The historical data trend for Lifeline Scientific's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeline Scientific EV-to-FCF Chart

Lifeline Scientific Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.22 -10.81 -19.50 - -

Lifeline Scientific Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Lifeline Scientific's EV-to-FCF

For the Medical Devices subindustry, Lifeline Scientific's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifeline Scientific's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lifeline Scientific's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Lifeline Scientific's EV-to-FCF falls into.



Lifeline Scientific EV-to-FCF Calculation

Lifeline Scientific's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=26.666/4.449
=5.99

Lifeline Scientific's current Enterprise Value is £26.67 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lifeline Scientific's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2016 was £4.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lifeline Scientific  (LSE:LSI) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Lifeline Scientific's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.37/0.000
=N/A

Lifeline Scientific's share price for today is £1.37.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lifeline Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2016 was £0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Lifeline Scientific EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Lifeline Scientific's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifeline Scientific (LSE:LSI) Business Description

Traded in Other Exchanges
N/A
Address
Lifeline Scientific Inc was incorporated on October 1, 1998. The Company is in the business of delivering, to targeted medical markets, a portfolio of related proprietary technologies, which include devices, solutions, and protocols designed to maximize the use and availability of organs, tissues, and cells. It serves the kidney transplant market today with its LifePort product line, and also sells solutions to service the broader organ transplant industry. The Company operates in North America, Brazil, China and Rest of World.